Want to see ATNM full AI Analyst Report?
Actinium Pharmaceuticals (ATNM) Income Statement
2,294 Followers
Actinium Pharmaceuticals Income Statement
Last quarter (Q2 2026), Actinium Pharmaceuticals's total revenue was $35.00M. In Q2, Actinium Pharmaceuticals's net income was $27.90M. See Actinium Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| $ 90.00K | $ 0.00 | $ 81.00K | $ 1.03M | $ 1.14M | |
| $ 90.00K | $ -811.00K | $ 81.00K | $ 1.03M | $ 620.00K | |
| $ 36.34M | $ 41.31M | $ 52.00M | $ 35.13M | $ 25.58M | |
| Depreciation and Amortization | $ 821.00K | $ 811.00K | $ 790.00K | $ 699.00K | $ 524.00K |
| $ -33.07M | $ -37.43M | $ -48.03M | $ -32.32M | $ -24.25M | |
| $ -36.25M | $ -42.12M | $ -51.92M | $ -34.10M | $ -24.96M | |
| $ 2.36M | $ 3.88M | $ 3.10M | $ 1.09M | $ 190.00K | |
| $ -33.89M | $ -38.24M | $ -48.82M | $ -33.02M | $ -24.77M | |
| $ -33.89M | $ -38.24M | $ -48.82M | $ -33.02M | $ -24.77M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.09 | $ -1.27 | $ -1.83 | $ -1.37 | $ -1.20 |
| Diluted EPS | $ -1.09 | $ -1.27 | $ -1.83 | $ -1.37 | $ -1.20 |
| Weighted Average Shares Outstanding | 31.20M | 30.07M | 26.60M | 24.14M | 20.57M |
| Weighted Average Shares Outstanding (Diluted) | 31.20M | 30.07M | 26.60M | 24.14M | 20.57M |
Currency in USD
